tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
US Market
Advertisement

Telix Pharmaceuticals (TLPPF) Financial Statements

Compare
134 Followers

Telix Pharmaceuticals Financial Overview

Telix Pharmaceuticals's market cap is currently $3.40B. The company's EPS TTM is $0.00987015; its P/E ratio is 286.45; Telix Pharmaceuticals is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History

Telix Pharmaceuticals Debt to Assets

Telix Pharmaceuticals Cash Flow

Telix Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis